Bibliotecas PUC-SP - Busca Integrada

The present and future of measurable residual disease testing in acute myeloid leukemia

per James S. Blachly, Roland B. Walter, Christopher S. Hourigan
Publicat a Haematologica (2022-12-01)

Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia

per Gregory W. Roloff, Catherine Lai, Christopher S. Hourigan, Laura W. Dillon
Publicat a Journal of Clinical Medicine (2017-09-01)

Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

per Nestor R. Ramos, Clifton C. Mo, Judith E. Karp, Christopher S. Hourigan
Publicat a Journal of Clinical Medicine (2015-04-01)

Translocation (8;21) acute myeloid leukemia presenting as severe aplastic anemia

per Enkhtsetseg Purev, Bogdan Dumitriu, Christopher S. Hourigan, Neal S. Young, Danielle M. Townsley
Publicat a Leukemia Research Reports (2014-01-01)

Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia

per Laura W. Dillon, Sheida Hayati, Gregory W. Roloff, Ilker Tunc, Mehdi Pirooznia, Antonina Mitrofanova, Christopher S. Hourigan
Publicat a Haematologica (2019-02-01)

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia

per Bogdan Popescu, Sheenu Sheela, Julie Thompson, Sophia Grasmeder, Therese Intrater, Christin B. DeStefano, Christopher S. Hourigan, Catherine Lai
Publicat a Clinical Hematology International (2019-12-01)

B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia

per Meghali Goswami, Katherine E. Lindblad, Rahul Ramraj, Pradeep K. Dagur, Julie Thompson, J. Philip McCoy, Christopher S. Hourigan
Publicat a Clinical Hematology International (2020-07-01)

Detectable mutations precede late myeloid neoplasia in aplastic anemia

per Bhavisha A. Patel, Jack Ghannam, Emma M. Groarke, Meghali Goswami, Laura Dillon, Fernanda Gutierrez-Rodrigues, Olga Rios, Diego Quinones Raffo, Jennifer Lotter, Neal S. Young, Christopher S. Hourigan
Publicat a Haematologica (2020-09-01)

Utility of plasma cell-free DNA for <i>de novo</i> detection and quantification of clonal hematopoiesis

per Fernanda Gutierrez-Rodrigues, Isabel Beerman, Emma M. Groarke, Bhavisha A. Patel, Nina Spitofsky, Laura W. Dillon, Diego Quinones Raffo, Christopher S. Hourigan, Sachiko Kajigaya, Luigi Ferrucci, Neal S. Young
Publicat a Haematologica (2021-09-01)

Identification of novel microRNA signatures linked to acquired aplastic anemia

per Kohei Hosokawa, Pawel Muranski, Xingmin Feng, Keyvan Keyvanfar, Danielle M. Townsley, Bogdan Dumitriu, Jichun Chen, Sachiko Kajigaya, James G. Taylor, Christopher S. Hourigan, A. John Barrett, Neal S. Young
Publicat a Haematologica (2015-12-01)

Prediction of HLA genotypes from single-cell transcriptome data

per Benjamin D. Solomon, Hong Zheng, Hong Zheng, Laura W. Dillon, Jason D. Goldman, Jason D. Goldman, Jason D. Goldman, Christopher S. Hourigan, James R. Heath, James R. Heath, Purvesh Khatri, Purvesh Khatri
Publicat a Frontiers in Immunology (2023-04-01)

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

per Laura W. Dillon, Jake Higgins, Hassan Nasif, Megan Othus, Lan Beppu, Thomas H. Smith, Elizabeth Schmidt, Charles C. Valentine III, Jesse J. Salk, Brent L Wood, Harry P. Erba, Jerald P. Radich, Christopher S. Hourigan
Publicat a Haematologica (2023-08-01)

Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation

per Lisa J. McReynolds, Yubo Zhang, Yanqin Yang, Jingrong Tang, Matthew Mulé, Amy P. Hsu, Danielle M. Townsley, Robert R. West, Jun Zhu, Dennis D. Hickstein, Steven M. Holland, Katherine R. Calvo, Christopher S. Hourigan
Publicat a Leukemia Research Reports (2019-01-01)

Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection

per Sheenu Sheela, Sawa Ito, Jeffrey R. Strich, Maura Manion, Celina Montemayor-Garcia, Hao-Wei Wang, Karolyn A. Oetjen, Kamile A. West, Austin J. Barrett, Mark Parta, Juan Gea-Banacloche, Steven M. Holland, Christopher S. Hourigan, Catherine Lai
Publicat a Leukemia Research Reports (2017-01-01)

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

per Sarah A. Buckley, Brent L. Wood, Megan Othus, Christopher S. Hourigan, Celalettin Ustun, Michael A. Linden, Todd E. DeFor, Michele Malagola, Chloe Anthias, Veronika Valkova, Christopher G. Kanakry, Bernd Gruhn, Francesco Buccisano, Beth Devine, Roland B. Walter
Publicat a Haematologica (2017-05-01)

Checkpoint immunotherapy is associated with preferential activation of tumor antigen–specific CD4+ T cells in MDS

per Elizabeth A. Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, Junko Matsuzaki, Kunle Odunsi, Laura W. Dillon, Devdeep Mukherjee, Christopher S. Hourigan, Jacqueline Peng, Shovik Bandyopadhyay, Kai Tan, Kristopher M. Attwood, Joseph B. Kuechle, Prashant K. Singh, Jianmin Wang, Michael J. Nemeth
Publicat a Blood Neoplasia (2025-08-01)

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

per Meghali Goswami, Gabrielle Prince, Angelique Biancotto, Susan Moir, Lela Kardava, Brian H. Santich, Foo Cheung, Yuri Kotliarov, Jinguo Chen, Rongye Shi, Huizhi Zhou, Hana Golding, Jody Manischewitz, Lisa King, Lauren M. Kunz, Kimberly Noonan, Ivan M. Borrello, B. Douglas Smith, Christopher S. Hourigan
Publicat a Journal of Translational Medicine (2017-07-01)

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response

per Hong Yuen Wong, Anthony D. Sung, Katherine E. Lindblad, Sheenu Sheela, Gregory W. Roloff, David Rizzieri, Meghali Goswami, Matthew P. Mulé, Nestor R. Ramos, Jingrong Tang, Julie Thompson, Christin B. DeStefano, Kristi Romero, Laura W. Dillon, Dong-Yun Kim, Catherine Lai, Christopher S. Hourigan
Publicat a Frontiers in Oncology (2019-01-01)

Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.

per Yaping Chang, Gordon H Guyatt, Trevor Teich, Jamie L Dawdy, Shaneela Shahid, Jessica K Altman, Richard M Stone, Mikkael A Sekeres, Sudipto Mukherjee, Thomas W LeBlanc, Gregory A Abel, Christopher S Hourigan, Mark R Litzow, Laura C Michaelis, Shabbir M H Alibhai, Pinkal Desai, Rena Buckstein, Janet MacEachern, Romina Brignardello-Petersen
Publicat a PLoS ONE (2021-01-01)

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia

per James L Gulley, Thomas Hughes, Jennifer L Marté, Katherine R Calvo, Meghali Goswami, Christopher S Hourigan, Gege Gui, Laura W Dillon, Katherine E Lindblad, Julie Thompson, Janet Valdez, Dong-Yun Kim, Jack Y Ghannam, Karolyn A Oetjen, Christin B Destefano, Dana M Smith, Hanna Tekleab, Yeusheng Li, Pradeep Dagur, Jaydira del Rivero, Joanna Klubo-Gwiezdzinksa, Catherine Lai
Publicat a Journal for ImmunoTherapy of Cancer (2022-01-01)